Nuvalent (NUVL) Change in Account Payables (2020 - 2026)
Nuvalent (NUVL) posted Change in Account Payables of -$7.7 million for Q1 2026, down 198.39% on a QoQ basis from $7.8 million in Q4 2025, and down 136.71% year-over-year from $20.9 million in Q1 2025.
Nuvalent (NUVL) Change in Account Payables (2020 - 2026) Analysis & Trends
Nuvalent's Change in Account Payables history runs 7 years deep, the most recent figure standing at -$7.7 million for Q1 2026.
- Quarterly Change in Account Payables fell 136.71% year-over-year to -$7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.0 million (down 131.55% YoY) and the FY2025 annual result came in at $24.6 million, up 707.53% from the prior year.
- Change in Account Payables was -$7.7 million for Q1 2026 at Nuvalent, down from $7.8 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $20.9 million in Q1 2025 and bottomed at -$12.8 million in Q2 2025.
- A 5-year average of $1.1 million and a median of $1.4 million in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables jumped 872.48% — and 2024, when it sank 1996.45%.
- Nuvalent's Change in Account Payables stood at $2.5 million in 2022, then sank by 120.4% to -$507000.0 in 2023, then sank by 1996.45% to -$10.6 million in 2024, then surged by 173.52% to $7.8 million in 2025, then sank by 198.39% to -$7.7 million in 2026.
- Business Quant data shows NUVL's Change in Account Payables at -$7.7 million in Q1 2026, $7.8 million in Q4 2025, and $8.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | -7.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.69 Mn |
| Mar 31, 2026 | -7.69 Mn |
| Dec 31, 2025 | 7.81 Mn |
| Dec 31, 2025 | 7.81 Mn |
| Sep 30, 2025 | 8.67 Mn |
| Sep 30, 2025 | 8.67 Mn |
| Jun 30, 2025 | -12.82 Mn |
| Jun 30, 2025 | -12.82 Mn |
| Mar 31, 2025 | 20.94 Mn |
| Mar 31, 2025 | 20.94 Mn |
| Dec 31, 2024 | -10.63 Mn |
| Dec 31, 2024 | -10.63 Mn |
| Sep 30, 2024 | 8.45 Mn |
| Sep 30, 2024 | 8.45 Mn |
| Jun 30, 2024 | -5.99 Mn |
| Jun 30, 2024 | -5.99 Mn |
| Mar 31, 2024 | 4.12 Mn |
| Mar 31, 2024 | 4.12 Mn |
| Dec 31, 2023 | -507,000.00 |
| Dec 31, 2023 | -507,000.00 |